(NXL)
0.00
0.00 (0.00%)
Get all premium features to the best stock analysis tool
0.00
0.00 (0.00%)
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
| Name | Position |
|---|---|
| Dr. David Owens M.D. | Chief Medical Officer, Member of Scientific Advisory Board & Director |
| Mr. John Patrick Claude | Co-Founder and Director of Engineering & Development |
| Mr. Justin Van Fleet CPA | Chief Financial Officer |
| Mr. Mark White | President, CEO & Director |
| Ms. Carolyn Shelton | Executive VP of Clinical, Quality & Regulatory Affairs |
| Date | Type | Document |
|---|---|---|
| 2026-01-23 | 8-K | nexalintech_8k.htm |
| 2025-12-05 | 8-K | nexalintech_8k.htm |
| 2025-11-14 | 10-Q | nexalintechno_10q.htm |
| 2025-10-15 | 8-K | nexalintech_8k.htm |
| 2025-09-23 | 10-K/A | nexalintech_10ka.htm |
| 2025-09-22 | 8-K | nexalintech_8k.htm |
| 2025-08-06 | 10-Q | nexalintechno_10q.htm |
| 2025-08-04 | 8-K | nexalintech_8k.htm |
| 2025-07-21 | 8-K | nexalintec_8k.htm |
| 2025-07-17 | 8-K | nexalintec_8k.htm |